2024-03-06 23:19:04 ET
Summary
- BrainsWay reported strong growth and a small profit in the fourth quarter of 2023. The company also gave strong guidance for 2024.
- Recent strength internationally and amongst larger customers is expected to persist. In addition, the commercialization of smoking cessation and ongoing trials could provide a further boost.
- The market is yet to fully price in the strength of BrainsWay's business, meaning the stock should continue to rerate higher as BrainsWay's profitable growth trajectory becomes more recognized.
BrainsWay ( BWAY ) is going from strength to strength as market headwinds ease, reporting another quarter of strong growth and reaching profitability. The company also gave strong guidance for 2024, providing further justification for the stock to continue rerating higher. None of this should be surprising for people who have followed my coverage of the stock , but the market and analysts continue to underestimate BrainsWay and the progress it is making.
Misconceptions
Coverage of BrainsWay has increased in recent months as the stock price has ballooned, but the stock still seems to be poorly understood....
Read the full article on Seeking Alpha
For further details see:
BrainsWay: Profitable, Growing, And Cheap